PHARMACY

Two senators urge GSK to end Shingrix shingles vaccine shortage
Although GlaxoSmithKline said it has developed a “fair and equitable” process to ship Shingrix, its new shingles vaccine, two U.S. senators are urging the drugmaker do more to boost inventory levels in the wake of a shortage.
Acadia gets FDA nod for Nuplazid in capsule, tablet strengths
Acadia received FDA approval for a new capsule dose formulation and tablet strength of Nuplazid.

Novartis’ Sandoz acquires U.S. rights for Adamis’ EpiPen alternative

Adamis Pharmaceuticals has entered into an exclusive distribution and commercialization agreement with Swiss drug company Novartis’ Sandoz division to commercialize Adamis’ Symjepi.
Albertsons piloted Idaho expanded prescribing before July 1 enactment

Albertsons pharmacies were given agency approval to pilot Idaho’s new prescribing authority, which took effect July 1, making it the first large retail chain pharmacy in the nation to offer these expanded services.
Medisca, FlavoRx partner on product roll out in Canada

Medisca's collaboration with FlavoRx will bring better tasting prescription medicines to children and pets in Canada.
Florida's drug price transparency law takes effect

Pharmacists in Florida can now share cost information with patients, thanks to a new law that took effect July 1.
FDA withdraws draft guidance on biosimilars

Key factors in the decision included comments noting that the number of reference product lots biosimilar developers would need to purchase under the draft guidance if it were finalized could impact cost and efficiency.
Speculation on Amazon's prescription sales begins

Amazon’s purchase of online pharmacy PillPack, set to close in the second half of the year, could enable the company to sell generic or branded prescription medications as soon as the deal closes, according to CNBC.
Mayne Pharma adds industry vet to board

Patrick Blake was most recently McKesson executive vice president and group president of McKesson Technology Solutions from 2009 to 2017.
Zydus Cadila gets FDA approval for Adalat CC, Questran generics

Drug firm Zydus Cadila has received the Food and Drug Administration’s nod for generic Adalat CC (nifedipine extended-release tablets), and for generic Questran (cholestyramine for oral suspension).